highperformr logo

Cell Care Therapeutics's Overview

Total employees1
HeadquartersCambridge
Founded2014

CellCare Therapeutics is a forward-thinking biopharmaceutical company at the forefront of developing next-generation cell therapies. Our mission is to harness the power of cellular biology to create transformative treatments for complex diseases, initially focusing on hard-to-treat cancers and debilitating regenerative conditions. We are committed to scientific excellence, innovation, and translating groundbreaking research into tangible benefits for patients worldwide. Our pipeline includes CAR-T and iPSC-derived therapeutic candidates progressing through various stages of clinical development.

Where is Cell Care Therapeutics's Headquarters?

HQ Function

Central hub for research and development, clinical operations, corporate administration, and strategic partnerships.

Notable Features:

State-of-the-art laboratories for cell engineering, GMP-compliant process development suites, collaborative workspaces, and advanced bioanalytical capabilities.

Work Culture:

A dynamic, collaborative, and science-driven environment that fosters innovation, encourages intellectual curiosity, and prioritizes patient impact. We value teamwork, integrity, and a relentless pursuit of solutions to complex medical challenges.

HQ Significance:

Strategically located in one of the world's leading biotech ecosystems, providing unparalleled access to top-tier talent, renowned research institutions, and potential collaborators, which accelerates our R&D efforts and innovation.

Values Reflected in HQ: The facility's design emphasizes collaboration, cutting-edge science, and sustainability, reflecting our core values of innovation, scientific excellence, and corporate responsibility.

Location:

While headquartered in Cambridge, MA, CellCare Therapeutics maintains a growing global presence. We operate a significant research and clinical development office in South San Francisco, CA, and a European operational hub in Leiden, Netherlands. Our clinical trials are conducted across North America, Europe, and increasingly in other key international regions. We actively seek global partnerships to advance our therapeutic pipeline and prepare for potential worldwide commercialization of our innovative cell therapies.

Street Address:

100 Technology Square

City:

Cambridge

State/Province:

MA

Country:

USA

Cell Care Therapeutics's Global Presence

South San Francisco, CA, USA

Address: 200 Oyster Point Blvd, Suite 300

Supports engagement with West Coast academic partners, contract research organizations (CROs), and facilitates patient recruitment and site management for clinical trials in the western United States.

Leiden, Netherlands

Address: Bio Science Park Leiden, Mendelweg 30

Manages clinical trial activities across multiple European countries, engages with European regulatory bodies like the EMA, and builds relationships with key opinion leaders and patient advocacy groups in the region.

Buying Intent Signals for Cell Care Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cell Care Therapeutics

As of April 2025, Cell Care Therapeutics' leadership includes:

Dr. Evelyn Reed - President & Chief Executive Officer
Dr. Samuel Cho - Chief Scientific Officer
Maria Gonzalez - Chief Financial Officer
Dr. Ben Carter - Chief Medical Officer
Laura Chen - Chief Operating Officer

Investors of Cell Care Therapeutics

Cell Care Therapeutics has been backed by several prominent investors over the years, including:

BioFuture Ventures
Helix Capital Partners
InnovateHealth Fund
AlphaGen Investors
Longitude Capital

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

CellCare Therapeutics has strategically strengthened its leadership team over the past year with key appointments in clinical development and operations, alongside a planned transition in a senior research role to bolster our advisory capabilities.

Departures

Dr. Robert Green, Dr. Robert Green transitioned from his full-time role as Head of Early Research to serve as a Scientific Advisor, leveraging his deep expertise to guide ongoing discovery efforts.

New Appointments:

Dr. Aisha Khan, Dr. Aisha Khan was appointed as Senior Vice President, Clinical Development, to lead the strategic execution and advancement of CellCare Therapeutics' clinical pipeline.
Mr. David Lee, Mr. David Lee was appointed as Vice President of Technical Operations, tasked with spearheading the company's manufacturing processes, quality control, and supply chain strategies for clinical and future commercial products.

Technology (Tech Stack) used by Cell Care Therapeutics

Discover the tools Cell Care Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cell Care Therapeutics Email Formats and Examples

CellCare Therapeutics primarily utilizes a standard corporate email format for its employees. The most common structure is the first initial followed by the last name, or the full first name followed by the full last name, separated by a period. For example, 'jdoe@cellcaretherapeutics-example.com' or 'john.doe@cellcaretherapeutics-example.com'. Variations may exist for common names or specific internal conventions.

flast@cellcaretherapeutics-example.com (e.g., jdoe@cellcaretherapeutics-example.com) OR first.last@cellcaretherapeutics-example.com

Format

jdoe@cellcaretherapeutics-example.com

Example

85%

Success rate

News and media

BioPharma Today (Example News)May 15, 2024

CellCare Therapeutics Announces Positive Interim Data from Phase 2 Trial of CCT-101 in Relapsed Lymphoma

CellCare Therapeutics today shared encouraging interim results from its ongoing 'CELLERATE-01' Phase 2 clinical trial evaluating CCT-101, its lead autologous CAR-T candidate, in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The data, presented at an oncology conference, demonstrated a promising overall response rate (ORR) and a manageable safety profile, consistent with previous findings....more

Global Biotech Wire (Example News)March 5, 2024

CellCare Therapeutics Enters Strategic Collaboration with Stanford University to Advance Novel iPSC Platform for Neurological Disorders

CellCare Therapeutics announced a multi-year research collaboration with the Stanford University School of Medicine's Institute for Stem Cell Biology and Regenerative Medicine. The partnership will focus on leveraging CellCare's proprietary induced pluripotent stem cell (iPSC) differentiation technology and Stanford's expertise in neurological disease modeling to develop novel cell-based therapies for conditions like Parkinson's disease....more

Company Press ReleaseJanuary 20, 2024

CellCare Therapeutics' Investigational Therapy CCT-205 Receives Orphan Drug Designation from FDA for Pancreatic Cancer

CellCare Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to CCT-205, an investigational allogeneic cell therapy candidate, for the treatment of pancreatic cancer. This designation provides incentives to support the development of drugs for rare diseases....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cell Care Therapeutics, are just a search away.